Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOTICGeneric

TERRAMYCIN W/ POLYMYXIN

OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE

Standard Dose
EQ 5MG BASE/GM;10,000 UNITS/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TERRAMYCIN W/ POLYMYXIN is listed in Drugs@FDA under application 061841 (ANDA).

Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE Form and strength OINTMENT;OTIC - EQ 5MG BASE/GM;10,000 UNITS/GM Sponsor PFIZER Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview TERRAMYCIN W/ POLYMYXIN is listed in Drugs@FDA under application 061841 (ANDA). Marketing status: Discontinued Active ingredient OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE Form and strength OINTMENT;OTIC - EQ 5MG BASE/GM;10,000 UNITS/GM Sponsor PFIZER Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.